- Home
- TRI vs IQV Comparison
TRI vs IQV Comparison
Compare TRI & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TRI | IQV |
|---|---|---|
| Founded | 1851 | 1982 |
| Country | Canada | United States |
| Employees | N/A | 93000 |
| Industry | | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.5B | 28.6B |
| IPO Year | 2002 | 2013 |
Fundamental Metrics
Financial Performance| Metric | TRI | IQV |
|---|---|---|
| Price | $76.73 | $166.47 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 16 |
| Target Price | $154.58 | ★ $227.13 |
| AVG Volume (30 Days) | ★ 1.8M | 1.6M |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.62% | N/A |
| EPS Growth | N/A | ★ 4.67 |
| EPS | N/A | ★ 1.61 |
| Revenue | N/A | ★ $9,739,000,000.00 |
| Revenue This Year | $8.90 | $6.77 |
| Revenue Next Year | $7.89 | $5.89 |
| P/E Ratio | ★ $25.72 | $104.20 |
| Revenue Growth | N/A | ★ 41.60 |
| 52 Week Low | $77.08 | $154.50 |
| 52 Week High | $218.40 | $247.05 |
Technical Indicators
Market Signals| Indicator | TRI | IQV |
|---|---|---|
| Relative Strength Index (RSI) | 36.33 | 38.63 |
| Support Level | N/A | $159.53 |
| Resistance Level | $93.19 | $182.20 |
| Average True Range (ATR) | 3.24 | 6.33 |
| MACD | -0.49 | -2.07 |
| Stochastic Oscillator | 1.39 | 15.07 |
Price Performance
Historical ComparisonAbout TRI Thomson Reuters Corp
Thomson Reuters is a leading global provider of business information services, delivering trusted data, technology, and expertise to professionals across legal, tax, accounting, risk, compliance, and the news and media sectors. Headquartered in Toronto, Canada, the company combines deep domain knowledge with data and software solutions to help clients make informed decisions, manage complexity, and drive efficiency. Thomson Reuters serves legal and accounting/tax professionals, corporations, and governments worldwide, but around 75% of revenue is generated in the US. The company is known for flagship products such as Westlaw, UltraTax CS, and Reuters News.
About IQV IQVIA Holdings Inc.
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its reserach and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.